Literature DB >> 7247353

Antimicrobial susceptibility of Capnocytophaga.

S W Forlenza, M G Newman, A L Horikoshi, U Blachman.   

Abstract

Capnocytophaga (Bacteroides ochraceus, Center for Disease Control biogroup DF-1) is associated with sepsis in granulocytopenic patients and is isolated in large numbers from the affected periodontal pockets in patients with juvenile periodontosis. The minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations (MBCs) of 17 antimicrobial agents for 13 strains of Capnocytophaga organisms were determined. In addition, the ratio of the MBC to the MIC for each antimicrobial agent was determined for each strain. At concentrations of 1 microgram/ml or less, penicillin, ampicillin, carbenicillin, erythromycin, and clindamycin killed 90% of the strains. At concentrations of 3.12 microgram/ml or less, tetracycline, metronidazole, cefoxitin, and chloramphenicol killed 90% of the strains. None of the aminoglycosides tested demonstrated antibacterial activity at 50 microgram/ml. Penicillin, ampicillin, carbenicillin, and cefoxitin exhibited MBC/MIC ratios of 4 or less with all strains. Erythromycin, tetracycline, and metronidazole exhibited MBC/MIC ratios of 4 or less for 12 of 13 strains. The MICs of cephalothin and cefazolin for 90% of the strains were 25 and 50 microgram/ml, respectively. The MBC/MIC ratios for these drugs were 4 or less for 12 of 13 and 7 of 13 strains, respectively. The MIC of cefamandole for 90% of the strains was 3.12 microgram/ml; however, only nine strains had an MBC/MIC ratio of 4 or less.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247353      PMCID: PMC181373          DOI: 10.1128/AAC.19.1.144

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients.

Authors:  S W Forlenza; M G Newman; A I Lipsey; S E Siegel; U Blachman
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

2.  Studies of the microbiology of periodontosis.

Authors:  M G Newman; S S Socransky; E D Savitt; D A Propas; A Crawford
Journal:  J Periodontol       Date:  1976-07       Impact factor: 6.993

3.  Detection, identification, and comparison of Capnocytophaga, Bacteroides ochraceus, and DF-1.

Authors:  M G Newman; V L Sutter; M J Pickett; U Blachman; J R Greenwood; V Grinenko; D Citron
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

4.  Synonymy of strains of Center for Disease Control group DF-1 with species of Capnocytophaga.

Authors:  B L Williams; D Hollis; L V Holdeman
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

  4 in total
  19 in total

1.  Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.

Authors:  A Rosenau; B Cattier; N Gousset; P Harriau; A Philippon; R Quentin
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.

Authors:  D L Roscoe; S J Zemcov; D Thornber; R Wise; A M Clarke
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

3.  Molecular identification of Capnocytophaga spp. via 16S rRNA PCR-restriction fragment length polymorphism analysis.

Authors:  Marilou Ciantar; Hubert N Newman; Michael Wilson; David A Spratt
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.

Authors:  J L Rummens; B Gordts; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

5.  Eight cases of Capnocytophaga infections in Denmark.

Authors:  A Bremmelgaard; J E Kristiansen; C Pers; W Frederiksen; B Korner; S S Schrøder
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

6.  In vitro susceptibility of Capnocytophaga species to antimicrobial agents.

Authors:  P M Hawkey; S D Smith; J Haynes; H Malnick; S W Forlenza
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

7.  Novel beta-lactamase from Capnocytophaga sp.

Authors:  J E Foweraker; P M Hawkey; J Heritage; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

8.  Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria.

Authors:  P J Baker; J Slots; R J Genco; R T Evans
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

9.  Two cases of Capnocytophaga bacteremia, one with endocarditis.

Authors:  M Montejo Baranda; V Acha Arrieta; J Hernandez Almaraz; M Perez Rodriguez; M Antoñana Oraeta; C Aguirre Errasti
Journal:  Can Med Assoc J       Date:  1984-06-01       Impact factor: 8.262

10.  Septic arthritis involving Capnocytophaga ochracea.

Authors:  R E Winn; W F Chase; P W Lauderdale; F K McCleskey
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.